---
type: Guide
title: "Berberine: What the Blood-Sugar Trials Show, and What 'GLP-1 Activator' Really Means"
description: "Against metformin, berberine 500 mg three times daily moved HbA1c from 9.5% to 7.5% over three months, with transient gastrointestinal effects in 34.5% of participants (PMID 18442638)."
resource: "https://4well.com/blogs/news/berberine-supplement-guide-blood-sugar-glp-1"
tags: [metabolic, guide, evidence]
timestamp: 2026-09-17T00:00:00Z
---

# Berberine: What the Blood-Sugar Trials Show, and What 'GLP-1 Activator' Really Means

Against metformin, berberine 500 mg three times daily moved HbA1c from 9.5% to 7.5% over three months, with transient gastrointestinal effects in 34.5% of participants (PMID 18442638). The GLP-1 mechanism was observed in rats and cells (PMID 19945441), not people.

- Published: 2026-09-03
- Read: https://4well.com/blogs/news/berberine-supplement-guide-blood-sugar-glp-1
- Every trial in the guide links to its PubMed record; the guide ends with a References list and the same set is exposed as `citation[]` in its BlogPosting markup.
- Trials cited above: [PMID 18442638](https://pubmed.ncbi.nlm.nih.gov/18442638/), [PMID 19945441](https://pubmed.ncbi.nlm.nih.gov/19945441/)

## Related

- Topic: [Metabolic & glucose](okf-topics-metabolic.md)
- Formula discussed on the site for this topic: [Berberine Triple Strength](okf-products-berberine-triple-strength.md)

## Source

Summary written from the published guide (reviewed 2026-09-17). Guides are written by the formulation team from human trials; every dose claim links to its PubMed record; mixed and negative results are included; there is no clinician review and nothing on the site is medical advice.